ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,120.00
0.51%
Dow Jones
38,686.32
1.51%
Brent Oil
80.905
0.12%
Bitcoin
69,137.32
2.05%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Poniard Pharmaceuticals, Inc. (MM) (PARD)

  7. Poniard Pharmaceuticals, Inc. (MM) (PARD) News

PARD

Poniard Pharmaceuticals, Inc. (MM) (PARD)

Poniard Pharmaceuticals, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PARD
DateTimeSourceHeadlineSymbolCompany
01/03/20128:00AMMarketwiredPoniard Pharmaceuticals Common Stock to Be Delisted From Nasdaq Stock Market, Intention to List on OTC Bulletin BoardNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
12/23/20113:37PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
11/22/20112:13PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
11/21/20111:15PMMarketwiredPoniard Pharmaceuticals Announces Shareholders Approve Merger With ALLOZYNENASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
11/21/20119:00AMMarketwiredSteps in the Right Direction - Featured Research on Poniard Pharmaceuticals, Inc. and Gilead Sciences, Inc.NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
11/18/20111:00PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
11/18/20118:30AMMarketwiredPoniard Pharmaceuticals Announces Licensing Agreement for Focal Adhesion Kinase TechnologyNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
11/10/20112:54PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
11/09/20111:16PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
11/09/20118:30AMMarketwiredISS Proxy Advisory Services Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse St...NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
11/08/20116:05AMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
11/07/20118:30AMMarketwiredGlass Lewis Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse Stock SplitNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
11/04/20116:10AMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
11/02/20114:01PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/28/20114:16PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/28/20114:01PMMarketwiredPoniard Pharmaceuticals Reports Third Quarter 2011 Financial ResultsNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/28/20111:59PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/28/201111:19AMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/28/20118:30AMMarketwiredEgan-Jones Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse Stock SplitNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/24/20113:47PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/21/20112:00PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/12/20111:43PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/12/20111:41PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/12/20111:37PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/11/20119:10AMDow Jones NewsRegistration Effectiveness Orders Issued By The SECNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/11/20116:00AMEdgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/07/20115:43PMMarketwiredPoniard Pharmaceuticals Announces Effectiveness of Form S-4 Registration Statement for the Proposed Merger with ALLOZYNENASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/07/20115:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/07/20115:26PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
10/07/20111:22PMEdgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:PARD

Your Recent History

LSE
ZEN
Zenith Energy
COIN
PHBUST
Phoenix Global
TG
NFR
Nisshin Seifun
UPBT
METABTC
Metadium
BMF
DIFU24V24
DIFU24V24 - 09/2024
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved